drugset / Trial / NCT01153581
Sex Hormones and Orthostatic Tolerance
Phase 2
Completed
109 enrolled
Yale University
National Heart, Lung, and Blood Institute (NHLBI) · collab
Non-randomizedSingle-groupOpen-labelBasic science
Summary
This study is designed to determine the causes of "orthostatic intolerance" which occurs more commonly in women than in men. Orthostatic tolerance is the ability to remain standing up right for long periods of time, or to avoid dizziness when moving to standing from a seated or lying position.
Timeline
- Start
- 2006-02
- Primary completion
- 2012-12
- Completion
- 2013-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Estradiol | Other / unclassified | 0.2 mg | Other |
| Subject | Ganirelix | Protein / enzyme biologic | 250 ug | Subcutaneous |
| Subject | Progesterone | Other / unclassified | 200 mg | Oral |
Indications
No indication recorded.